Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...
At this time, I would like to welcome everyone to the Q3 2024 Emergent BioSolutions Inc. earnings conference call. All lines ...
Q3 2024 Earnings Call Transcript November 6, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...
Zacks.com on MSN5d
Emergent Biosolutions (EBS) Q3 Earnings Beat EstimatesEmergent Biosolutions (EBS) delivered earnings and revenue surprises of 179.59% and 10.62%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the ...
Emergent Biosolutions ( (EBS) ) has released its Q3 earnings. Here is a breakdown of the information Emergent Biosolutions presented to its ...
On a per-share basis, the Gaithersburg, Maryland-based company said it had profit of $2.06. Earnings, adjusted for non-recurring gains, were $1.37 per share. The biopharmaceutical company posted ...
Reports Q3 revenue $293.8M vs. $270.5M last year. “Through disciplined execution and steady, measurable progress, Emergent’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback